BIO-TECHNE Corp vs Direxion Daily TSLA Bull 2X Shares — how do they compare? BIO-TECHNE Corp trades at $71.63 (market cap $11.16B), while Direxion Daily TSLA Bull 2X Shares trades at $11.26. The key difference: BIO-TECHNE Corp pays a 0.45% dividend while Direxion Daily TSLA Bull 2X Shares pays none, and BIO-TECHNE Corp is trading nearer its 52-week high, Direxion Daily TSLA Bull 2X Shares nearer its low. Which is the better fit depends on your goals.
| TECH | TSLL | |
|---|---|---|
Market Cap | $11.16B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $72.12 | $23.03 |
52-Week Low | $43.31 | $10.29 |
Enterprise Value | $11.24B | — |
Dividend Yield | 0.45% | — |
Trailing returns across standard periods
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →